| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.29▼ | 3.29▼ | 3.27▼ | 3.22▲ | 3.95▼ |
| MA10 | 3.26▼ | 3.25▲ | 3.23▲ | 3.42▼ | 5.56▼ |
| MA20 | 3.24▲ | 3.26▼ | 3.28▼ | 4.03▼ | 6.69▼ |
| MA50 | 3.40▼ | 3.60▼ | 3.82▼ | 5.90▼ | 22.62▼ |
| MA100 | 3.91▼ | 4.63▼ | 5.06▼ | 6.92▼ | 29.63▼ |
| MA200 | 5.29▼ | 6.08▼ | 6.38▼ | 19.05▼ | 36.16▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.021▲ | 0.042▲ | 0.056▲ | 0.024▲ | 0.607▲ |
| RSI | 43.517▼ | 38.494▼ | 33.261▼ | 18.771▼ | 25.236▼ |
| STOCH | 73.677 | 76.687 | 73.573 | 13.318▼ | 3.959▼ |
| WILL %R | -38.235 | -38.235 | -38.235 | -85.806▼ | -95.792▼ |
| CCI | 17.152 | 26.994 | 47.981 | -67.555 | -127.301▼ |
| ▲ MACD | $IMMP MACD(12,26,9) Crossed Above Signal Line | Set Alert |
|
Monday, October 19, 2026 05:00 AM
Late-breaking poster will present data from the first-in-human Phase I study of IMP761, a first-in-class LAG-3 agonist antibody, in healthy volunteers SYDNEY, AUSTRALIA, Oct. 19, 2026 (GLOBE NEWSWIRE) ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 21/10/26 | 3.22 | 3.395 | 3.21 | 3.28 | 9,209 |
| 20/10/26 | 3.15 | 3.4195 | 3.15 | 3.26 | 16,369 |
| 19/10/26 | 3.29 | 3.29 | 3.13 | 3.17 | 6,783 |
| 16/10/26 | 3.27 | 3.27 | 3.18 | 3.20 | 11,868 |
| 15/10/26 | 3.31 | 3.31 | 3.06 | 3.21 | 19,070 |
| 14/10/26 | 3.48 | 3.54 | 3.36 | 3.38 | 38,702 |
| 13/10/26 | 3.60 | 3.70 | 3.437 | 3.57 | 26,994 |
| 12/10/26 | 3.57 | 3.70 | 3.56 | 3.67 | 18,623 |
| 09/10/26 | 3.785 | 3.785 | 3.55 | 3.63 | 23,406 |
| 08/10/26 | 4.02 | 4.1036 | 3.80 | 3.84 | 14,904 |
|
|
||||
|
|
||||
|
|